drugset / Trial / NCT01159275
Lopinavir (LPV) Dose Reduction
Phase 1/2
Completed
20 enrolled
The HIV Netherlands Australia Thailand Research Collaboration
Ministry of Education, Thailand · collab
RandomizedCrossoverOpen-labelOther
Summary
The purpose of this study is to study the pharmacokinetics profiles of generic lopinavir/ritonavir and Pediatric Aluvia® at reduced dose by assessing safety, tolerability and efficacy.
Timeline
- Start
- 2009-07
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lopinavir/Ritonavir | Unknown | — | — |